Drug Trial Radar · NCT03278509
Evaluation of Decreased Usage of Betablockers After Myocardial Infarction in the SWEDEHEART Registry (REDUCE-SWEDEHEART)
Last checked: Nov 19, 2026Latest source record: Mar 5, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
5,000
Planned (sponsor's estimate)
Start
Sep 11, 2017
Primary completion
Nov 16, 2023
Study completion Dec 31, 2025
Sponsor
- Lead sponsor
- Karolinska InstitutetAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Uppsala University; The Swedish Research Council
- First posted
- Sep 11, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Long-term beta-blocker therapy has not been investigated in contemporary randomized clinical trials in patients with myocardial infarction and normal heart function. The aim of this study is to determine whether long-term treatment with oral beta-blockade in patients with myocardial infarction and preserved left ventricular systolic ejection fraction reduces the composite of death of any cause or new myocardial infarction..
Conditions
- Acute Myocardial Infarction
- Non-ST Elevation Myocardial Infarction
- ST Elevation Myocardial Infarction
Interventions
Metoprolol SuccinateDrug
Eligible patients randomized to active treatment will receive long-term oral beta-blockade (metoprolol succinate or bisoprolol).
BisoprololDrug
Please see the section above.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Time to the composite of death of any cause or MITime frame: through study completion, an average of 3 year
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Danderyd Hospital, Cardiac Intensive Care
Danderyd, Stockholm County, Sweden
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.